Mutant Erythropoietin without Erythropoietic Activity is Neuroprotective against Ischemic Brain Injury

BACKGROUND AND PURPOSE: Erythropoietin (EPO) confers potent neuroprotection against ischemic injury. However, treatment for stroke requires high doses and multiple administrations of EPO, which may cause deleterious side effects due to its erythropoietic activity. This study identifies a novel non-e...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gan, Yu, Xing, Juan, Jing, Zheng, Stetler, R. Anne, Zhang, Feng, Luo, Yumin, Ji, Xunmin, Gao, Yanqin, Cao, Guodong
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3479346/
https://ncbi.nlm.nih.gov/pubmed/22984011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.112.663120
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky